23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

[ad_1]

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *